Home>>Signaling Pathways>> Microbiology & Virology>> Bacterial>>Sulfamethoxazole

Sulfamethoxazole (Synonyms: NSC 147832, Ro 4-2130)

Catalog No.GC11874

sulfonamide bacteriostatic antibiotic

Products are for research use only. Not for human use. We do not sell to patients.

Sulfamethoxazole Chemical Structure

Cas No.: 723-46-6

Size Price Stock Qty
10mM (in 1mL DMSO)
$34.00
In stock
50mg
$48.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Sulfamethoxazole (Ro 4-2130) is a sulfonamide bacteriostatic antibiotic. Sulfamethoxazole is being used for human and veterinary applications[1].

Sulfonamides are structural analogs and competitive antagonists of para-aminobenzoic acid (PABA). They inhibit normal bacterial utilization of PABA for the synthesis of folic acid, an important metabolite in DNA synthesis. The effects seen are usually bacteriostatic in nature. Folic acid is not synthesized in humans, but is instead a dietary requirement. This allows for the selective toxicity to bacterial cells (or any cell dependent on synthesizing folic acid) over human cells. Bacterial resistance to sulfamethoxazole is caused by mutations in the enzymes involved in folic acid synthesis that prevent the drug from binding to it.

References:
[1]. Straub JO, et al. Aquatic environmental risk assessment for human use of the old antibiotic sulfamethoxazole in Europe. Environ Toxicol Chem. 2016 Apr;35(4):767-79.

Reviews

Review for Sulfamethoxazole

Average Rating: 5 ★★★★★ (Based on Reviews and 24 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Sulfamethoxazole

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.